Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Author(s):
Sonnenblick, A.; Agbor-Tarh, D.; Bradbury, I.; Cosimo, S. di; Azim, H.A.; Fumagalli, D.; Sarp, S.; Wolff, A.C.; Andersson, M.; Kroep, J.; Cufer, T.; Simon, S.D.; Salman, P.; Toi, M.; Harris, L.; Gralow, J.; Keane, M.; Moreno-Aspitia, A.; Piccart-Gebhart, M.; Azambuja, E. de
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-05-01
Language
English
Is part of
Journal of Clinical Oncology (2017), Vol. 35, no. 13, p. 1421-+
